Lannett reported $100.44M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Amerisourcebergen ABC:US $ 56939.29M 2045.12M
Ani Pharmaceuticals ANIP:US $ 83.67M 980K
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Canopy Growth Corp WEED:CN C$ 641.41M 350.48M
Cardinal Health CAH:US 44.93B 1.47B
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Depomed DEPO:US $ 24.98M 368K
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Knight Therapeutics Inc GUD:CN C$ 63.85M 8.85M
Lannett LCI:US $ 100.44M 54.15M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Mckesson MCK:US $ 65469M 2847M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NVS:US 9.96B 998M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Perrigo Ordinary Shares PRGO:US $ 1052.8M 5.4M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 189.51M 2.36M
Supernus Pharmaceuticals SUPN:US $ 150.54M 2.41M
Teva Pharmaceutical TEVA:IT 4.37B 352M
Zoetis ZTS:US $ 1.26B 202M